344 related articles for article (PubMed ID: 28341099)
21. Dissemination of aminoglycoside-modifying enzymes and 16S rRNA methylases among acinetobacter baumannii and Pseudomonas aeruginosa isolates.
Aghazadeh M; Rezaee MA; Nahaei MR; Mahdian R; Pajand O; Saffari F; Hassan M; Hojabri Z
Microb Drug Resist; 2013 Aug; 19(4):282-8. PubMed ID: 23577624
[TBL] [Abstract][Full Text] [Related]
22. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
Murray PR
Antimicrob Agents Chemother; 1980 Mar; 17(3):474-6. PubMed ID: 6252830
[TBL] [Abstract][Full Text] [Related]
23. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
Knothe H; Krcméry V; Mitsuhashi S
Zentralbl Bakteriol A; 1980 Mar; 246(3):373-8. PubMed ID: 6775445
[TBL] [Abstract][Full Text] [Related]
24. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
[TBL] [Abstract][Full Text] [Related]
25. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
26. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
27. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
29. In Vitro Efficacy of Doripenem against Pseudomonas aeruginosa and Acinetobacter baumannii by E-Test.
Gilani M; Munir T; Latif M; Rehman S; Ansari M; Hafeez A; Najeeb S; Saad N; Gilani M
J Coll Physicians Surg Pak; 2015 Oct; 25(10):726-9. PubMed ID: 26454387
[TBL] [Abstract][Full Text] [Related]
30. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)].
Campello C; Crevatin E
Ann Sclavo; 1977; 19(3):437-45. PubMed ID: 415672
[TBL] [Abstract][Full Text] [Related]
31. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
[TBL] [Abstract][Full Text] [Related]
32. Trends in aminoglycoside use and gentamicin-resistant gram-negative clinical isolates in US academic medical centers: implications for antimicrobial stewardship.
Ababneh M; Harpe S; Oinonen M; Polk RE
Infect Control Hosp Epidemiol; 2012 Jun; 33(6):594-601. PubMed ID: 22561715
[TBL] [Abstract][Full Text] [Related]
33. [Studies on the antimicrobial activities of gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa isolated at Hokkaido University Hospital].
Sato K; Matsumiya H; Saito A
Jpn J Antibiot; 1982 May; 35(5):1240-8. PubMed ID: 6813532
[TBL] [Abstract][Full Text] [Related]
34. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
Yasmin F; Akhtar N; Hameed A
Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin-intermediate Staphylococcus aureus clinical isolates.
Truelson KA; Brennan-Krohn T; Smith KP; Kirby JE
Diagn Microbiol Infect Dis; 2018 Oct; 92(2):168-171. PubMed ID: 29934071
[TBL] [Abstract][Full Text] [Related]
36. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa with phage F 116 and AP 19, a new wildtype phage.
Knothe H; Lebek G; Krcméry V; Seginková Z; Cervenka J; Antal M; Mitsuhashi S
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):506-10. PubMed ID: 6800151
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
Drugeon HB; Courtieu AL
Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
[TBL] [Abstract][Full Text] [Related]
38. In Vitro Activity of the Novel Antimicrobial Peptide Dendrimer G3KL against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Pires J; Siriwardena TN; Stach M; Tinguely R; Kasraian S; Luzzaro F; Leib SL; Darbre T; Reymond JL; Endimiani A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7915-8. PubMed ID: 26459893
[TBL] [Abstract][Full Text] [Related]
39. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.
Potron A; Poirel L; Nordmann P
Int J Antimicrob Agents; 2015 Jun; 45(6):568-85. PubMed ID: 25857949
[TBL] [Abstract][Full Text] [Related]
40. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
Christe M; Vaudaux P; Waldvogel FA
Schweiz Med Wochenschr; 1982 Feb; 112(7):234-41. PubMed ID: 6803358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
